{
    "xml": "<topic id=\"PHP4600\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/somatropin\" basename=\"somatropin\" title=\"SOMATROPIN\">\n<title>SOMATROPIN</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_848\" namespace=\"/interactions/list-of-drug-interactions/somatropin\">Somatropin</xref>\n</p>\n<data name=\"vtmid\">129495007</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_461212134\" title=\"Human growth hormones\">Human growth hormones</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n<p outputclass=\"synonyms\">Recombinant Human Growth Hormone</p>\r\n</body>\n<topic id=\"PHP65675\" outputclass=\"indicationsAndDose\" rev=\"1.46\" parent=\"/drugs/somatropin\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Gonadal dysgenesis (Turner syndrome)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By subcutaneous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>1.4&#8239;mg/m<sup>2</sup> daily, alternatively 45&#8211;50&#8239;micrograms/kg daily.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Deficiency of growth hormone</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By subcutaneous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 150&#8211;300&#8239;micrograms daily, then increased if necessary up to 1&#8239;mg daily, dose to be increased gradually, use minimum effective dose (requirements may decrease with age).</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"doseEquivalence\">\n<title>Dose equivalence and conversion</title>\n<p>Dose formerly expressed in units; somatropin 1&#8239;mg &#8801; 3&#8239;units.</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP65728\" outputclass=\"contraindications\" rev=\"1.7\" parent=\"/drugs/somatropin\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<p>\n<ph outputclass=\"contraindication\">Evidence of tumour activity (complete antitumour therapy and ensure intracranial lesions inactive before starting)</ph>; <ph outputclass=\"contraindication\">not to be used after renal transplantation</ph>; <ph outputclass=\"contraindication\">not to be used for growth promotion in children with closed epiphyses (or near closure in Prader-Willi syndrome)</ph>; <ph outputclass=\"contraindication\">severe obesity in Prader-Willi syndrome</ph>; <ph outputclass=\"contraindication\">severe respiratory impairment in Prader-Willi syndrome</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP65736\" outputclass=\"cautions\" rev=\"1.7\" parent=\"/drugs/somatropin\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Diabetes mellitus (adjustment of antidiabetic therapy may be necessary)</ph>; <ph outputclass=\"caution\">disorders of the epiphysis of the hip (monitor for limping)</ph>; <ph outputclass=\"caution\">history of malignant disease</ph>; <ph outputclass=\"caution\">hypothyroidism&#8212;manufacturers recommend periodic thyroid function tests but limited evidence of clinical value</ph>; <ph outputclass=\"caution\">initiation of treatment close to puberty not recommended in child born small for corrected gestational age</ph>; <ph outputclass=\"caution\">papilloedema</ph>; <ph outputclass=\"caution\">relative deficiencies of other pituitary hormones</ph>; <ph outputclass=\"caution\">resolved intracranial hypertension (monitor closely)</ph>; <ph outputclass=\"caution\">Silver-Russell syndrome</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP65666\" outputclass=\"interactions\" rev=\"1.6\" parent=\"/drugs/somatropin\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (somatropin).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP65637\" outputclass=\"sideEffects\" rev=\"1.8\" parent=\"/drugs/somatropin\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Antibody formation</ph>; <ph outputclass=\"sideEffect\">arthralgia</ph>; <ph outputclass=\"sideEffect\">benign intracranial hypertension</ph>; <ph outputclass=\"sideEffect\">carpal tunnel syndrome</ph>; <ph outputclass=\"sideEffect\">fluid retention (peripheral oedema)</ph>; <ph outputclass=\"sideEffect\">headache</ph>; <ph outputclass=\"sideEffect\">hyperglycaemia</ph>; <ph outputclass=\"sideEffect\">hypoglycaemia</ph>; <ph outputclass=\"sideEffect\">hypothyroidism</ph>; <ph outputclass=\"sideEffect\">insulin resistance</ph>; <ph outputclass=\"sideEffect\">leukaemia in children with growth hormone deficiency</ph>; <ph outputclass=\"sideEffect\">myalgia</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">papilloedema</ph>; <ph outputclass=\"sideEffect\">paraesthesia</ph>; <ph outputclass=\"sideEffect\">reactions at injection site</ph>; <ph outputclass=\"sideEffect\">visual problems</ph>; <ph outputclass=\"sideEffect\">vomiting</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsAdvice\">\n<title>Side-effects, further information</title>\n<sectiondiv>\n<p outputclass=\"title\">Papilloedema</p>\n<p>Funduscopy for papilloedema recommended if severe or recurrent headache, visual problems, nausea and vomiting occur&#8212;if papilloedema confirmed consider benign intracranial hypertension (rare cases reported).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP65661\" outputclass=\"pregnancy\" parent=\"/drugs/somatropin\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Discontinue if pregnancy occurs&#8212;no information available.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP65742\" outputclass=\"breastFeeding\" parent=\"/drugs/somatropin\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>No information available.</p>\n<p>Absorption from milk unlikely.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP65757\" outputclass=\"directionsForAdministration\" rev=\"1.7\" parent=\"/drugs/somatropin\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p>Rotate subcutaneous injection sites to prevent lipoatrophy.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP59223\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.8\" parent=\"/drugs/somatropin\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p>Medicinal products containing somatropin are not identical and although there should be no important differences in terms of safety and efficacy, when prescribing biological products it is good practice to use the brand name.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP65595\" outputclass=\"nationalFunding\" rev=\"1.14\" parent=\"/drugs/somatropin\">\n<title>National funding/access decisions</title>\n<body>\r\n<section>\r\n<sectiondiv outputclass=\"niceTechnologyAppraisals\">\r\n<p outputclass=\"title\">NICE technology appraisals (TAs)</p>\r\n<sectiondiv outputclass=\"niceTechnologyAppraisal\">\r\n<p outputclass=\"fundingIdentifier\">NICE TA64</p>\r\n<sectiondiv>\r\n<p outputclass=\"title\">Somatropin for adults with growth hormone deficiency (August 2003)</p>\r\n<p>Somatropin is recommended in adults <b>only</b> if the following 3 criteria are fulfilled:</p>\r\n<ul>\r\n<li>Severe growth hormone deficiency, established by an appropriate method,</li>\r\n<li>Impaired quality of life, measured by means of a specific questionnaire,</li>\r\n<li>Already receiving treatment for another pituitary hormone deficiency.</li>\r\n</ul>\r\n<p>Somatropin treatment should be discontinued if the quality of life has not improved sufficiently by 9 months.</p>\r\n<p>Severe growth hormone deficiency developing after linear growth is complete but before the age of 25 years should be treated with growth hormone; treatment should continue until adult peak bone mass has been achieved. Treatment for adult-onset growth hormone deficiency should be stopped only when the patient and the patient&#8217;s physician consider it appropriate.</p>\r\n<p>Treatment with somatropin should be initiated and managed by a physician with expertise in growth hormone disorders; maintenance treatment can be prescribed in the community under a shared-care protocol.</p>\n</sectiondiv>\n<xref format=\"html\" href=\"http://www.nice.org.uk/TA64\">www.nice.org.uk/TA64</xref>\n</sectiondiv>\r\n<sectiondiv outputclass=\"niceTechnologyAppraisal\">\r\n<p outputclass=\"fundingIdentifier\">NICE TA188</p>\r\n<sectiondiv>\r\n<p outputclass=\"title\">Somatropin for the treatment of growth failure in children (May 2010) </p>\r\n<p>Somatropin is recommended for children with growth failure who:</p>\r\n<ul>\r\n<li>have growth-hormone deficiency</li>\r\n<li>have Turner syndrome</li>\r\n<li>have Prader-Willi syndrome</li>\r\n<li>have chronic renal insufficiency</li>\r\n<li>are born small for gestational age with subsequent growth failure at 4 years of age or later</li>\r\n<li>have short stature homeobox-containing gene (SHOX) deficiency.</li>\r\n</ul>\r\n<p>Treatment should be discontinued if growth velocity increases by less than 50% from baseline in the first year of treatment.</p>\n</sectiondiv>\n<xref format=\"html\" href=\"http://www.nice.org.uk/TA188\">www.nice.org.uk/TA188</xref>\n</sectiondiv>\n</sectiondiv>\r\n </section>\r\n\r\n</body>\n</topic>\n<topic id=\"PHP4600-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/somatropin\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75165\" title=\"Solution for injection\" namespace=\"/drugs/somatropin/solution-for-injection\">Solution for injection</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75158\" title=\"Powder and solvent for solution for injection\" namespace=\"/drugs/somatropin/powder-and-solvent-for-solution-for-injection\">Powder and solvent for solution for injection</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP97239\" namespace=\"/guidance/controlled-drugs-and-drug-dependence\" title=\"Controlled drugs and drug dependence\" count=\"2\" rel=\"backlink\">Controlled drugs and drug dependence</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78434\" namespace=\"/treatment-summaries/hypothalamic-and-anterior-pituitary-hormones\" title=\"Hypothalamic and anterior pituitary hormones\" count=\"1\" rel=\"backlink\">Hypothalamic and anterior pituitary hormones</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_848\" namespace=\"/interactions/list-of-drug-interactions/somatropin\" title=\"Somatropin\" count=\"1\" rel=\"link\">Somatropin</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75165\" namespace=\"/drugs/somatropin/solution-for-injection\" title=\"Solution for injection\" count=\"1\" rel=\"link\">Solution for injection</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75158\" namespace=\"/drugs/somatropin/powder-and-solvent-for-solution-for-injection\" title=\"Powder and solvent for solution for injection\" count=\"1\" rel=\"link\">Powder and solvent for solution for injection</xref>\n</links>\n</topic>",
    "id": "PHP4600",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/somatropin",
    "basename": "somatropin",
    "title": "SOMATROPIN",
    "interactants": [
        {
            "id": "bnf_int_848",
            "label": "Somatropin"
        }
    ],
    "vtmid": "129495007",
    "drugClassification": [
        "Human growth hormones"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "synonyms": [
        "Recombinant Human Growth Hormone"
    ],
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Gonadal dysgenesis (Turner syndrome)",
                        "html": "Gonadal dysgenesis (Turner syndrome)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "subcutaneous injection"
                    ],
                    "textContent": "By subcutaneous injection",
                    "html": "By subcutaneous injection"
                },
                "adult": [
                    {
                        "textContent": "1.4 mg/m2 daily, alternatively 45&#8211;50 micrograms/kg daily.",
                        "html": "<p>1.4&#8239;mg/m<sup>2</sup> daily, alternatively 45&#8211;50&#8239;micrograms/kg daily.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Deficiency of growth hormone",
                        "html": "Deficiency of growth hormone"
                    }
                ],
                "specificity": {
                    "routes": [
                        "subcutaneous injection"
                    ],
                    "textContent": "By subcutaneous injection",
                    "html": "By subcutaneous injection"
                },
                "adult": [
                    {
                        "textContent": "Initially 150&#8211;300 micrograms daily, then increased if necessary up to 1 mg daily, dose to be increased gradually, use minimum effective dose (requirements may decrease with age).",
                        "html": "<p>Initially 150&#8211;300&#8239;micrograms daily, then increased if necessary up to 1&#8239;mg daily, dose to be increased gradually, use minimum effective dose (requirements may decrease with age).</p>"
                    }
                ]
            }
        ],
        "doseEquivalence": [
            {
                "type": "doseEquivalence",
                "title": "Dose equivalence and conversion",
                "textContent": "Dose formerly expressed in units; somatropin 1 mg &#8801; 3 units.",
                "html": "<p>Dose formerly expressed in units; somatropin 1&#8239;mg &#8801; 3&#8239;units.</p>"
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Evidence of tumour activity (complete antitumour therapy and ensure intracranial lesions inactive before starting)",
                "html": "Evidence of tumour activity (complete antitumour therapy and ensure intracranial lesions inactive before starting)"
            },
            {
                "type": "contraindications",
                "textContent": "not to be used after renal transplantation",
                "html": "not to be used after renal transplantation"
            },
            {
                "type": "contraindications",
                "textContent": "not to be used for growth promotion in children with closed epiphyses (or near closure in Prader-Willi syndrome)",
                "html": "not to be used for growth promotion in children with closed epiphyses (or near closure in Prader-Willi syndrome)"
            },
            {
                "type": "contraindications",
                "textContent": "severe obesity in Prader-Willi syndrome",
                "html": "severe obesity in Prader-Willi syndrome"
            },
            {
                "type": "contraindications",
                "textContent": "severe respiratory impairment in Prader-Willi syndrome",
                "html": "severe respiratory impairment in Prader-Willi syndrome"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Diabetes mellitus (adjustment of antidiabetic therapy may be necessary)",
                "html": "Diabetes mellitus (adjustment of antidiabetic therapy may be necessary)"
            },
            {
                "type": "cautions",
                "textContent": "disorders of the epiphysis of the hip (monitor for limping)",
                "html": "disorders of the epiphysis of the hip (monitor for limping)"
            },
            {
                "type": "cautions",
                "textContent": "history of malignant disease",
                "html": "history of malignant disease"
            },
            {
                "type": "cautions",
                "textContent": "hypothyroidism&#8212;manufacturers recommend periodic thyroid function tests but limited evidence of clinical value",
                "html": "hypothyroidism&#8212;manufacturers recommend periodic thyroid function tests but limited evidence of clinical value"
            },
            {
                "type": "cautions",
                "textContent": "initiation of treatment close to puberty not recommended in child born small for corrected gestational age",
                "html": "initiation of treatment close to puberty not recommended in child born small for corrected gestational age"
            },
            {
                "type": "cautions",
                "textContent": "papilloedema",
                "html": "papilloedema"
            },
            {
                "type": "cautions",
                "textContent": "relative deficiencies of other pituitary hormones",
                "html": "relative deficiencies of other pituitary hormones"
            },
            {
                "type": "cautions",
                "textContent": "resolved intracranial hypertension (monitor closely)",
                "html": "resolved intracranial hypertension (monitor closely)"
            },
            {
                "type": "cautions",
                "textContent": "Silver-Russell syndrome",
                "html": "Silver-Russell syndrome"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (somatropin).",
                "html": "<p>Appendix 1 (somatropin).</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Antibody formation",
                        "html": "Antibody formation",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "arthralgia",
                        "html": "arthralgia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "benign intracranial hypertension",
                        "html": "benign intracranial hypertension",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "carpal tunnel syndrome",
                        "html": "carpal tunnel syndrome",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "fluid retention (peripheral oedema)",
                        "html": "fluid retention (peripheral oedema)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "headache",
                        "html": "headache",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hyperglycaemia",
                        "html": "hyperglycaemia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hypoglycaemia",
                        "html": "hypoglycaemia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hypothyroidism",
                        "html": "hypothyroidism",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "insulin resistance",
                        "html": "insulin resistance",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "leukaemia in children with growth hormone deficiency",
                        "html": "leukaemia in children with growth hormone deficiency",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "myalgia",
                        "html": "myalgia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "papilloedema",
                        "html": "papilloedema",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "paraesthesia",
                        "html": "paraesthesia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "reactions at injection site",
                        "html": "reactions at injection site",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "visual problems",
                        "html": "visual problems",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "vomiting",
                        "html": "vomiting",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        },
        "advice": [
            {
                "type": "advice",
                "title": "Papilloedema",
                "textContent": "Funduscopy for papilloedema recommended if severe or recurrent headache, visual problems, nausea and vomiting occur&#8212;if papilloedema confirmed consider benign intracranial hypertension (rare cases reported).",
                "html": "<p>Funduscopy for papilloedema recommended if severe or recurrent headache, visual problems, nausea and vomiting occur&#8212;if papilloedema confirmed consider benign intracranial hypertension (rare cases reported).</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Discontinue if pregnancy occurs&#8212;no information available.",
                "html": "<p>Discontinue if pregnancy occurs&#8212;no information available.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "No information available.\n\nAbsorption from milk unlikely.",
                "html": "<p>No information available.</p><p>Absorption from milk unlikely.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "textContent": "Rotate subcutaneous injection sites to prevent lipoatrophy.",
                "html": "<p>Rotate subcutaneous injection sites to prevent lipoatrophy.</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "textContent": "Medicinal products containing somatropin are not identical and although there should be no important differences in terms of safety and efficacy, when prescribing biological products it is good practice to use the brand name.",
                "html": "<p>Medicinal products containing somatropin are not identical and although there should be no important differences in terms of safety and efficacy, when prescribing biological products it is good practice to use the brand name.</p>"
            }
        ]
    },
    "nationalFunding": {
        "niceTechnologyAppraisals": [
            {
                "type": "niceTechnologyAppraisals",
                "references": [
                    {
                        "id": "http://www.nice.org.uk/TA64",
                        "label": "www.nice.org.uk/TA64"
                    }
                ],
                "fundingIdentifier": "NICE TA64",
                "textContent": "Somatropin for adults with growth hormone deficiency (August 2003) Somatropin is recommended in adults only if the following 3 criteria are fulfilled: Severe growth hormone deficiency, established by an appropriate method, Impaired quality of life, measured by means of a specific questionnaire, Already receiving treatment for another pituitary hormone deficiency. Somatropin treatment should be discontinued if the quality of life has not improved sufficiently by 9 months. Severe growth hormone deficiency developing after linear growth is complete but before the age of 25 years should be treated with growth hormone; treatment should continue until adult peak bone mass has been achieved. Treatment for adult-onset growth hormone deficiency should be stopped only when the patient and the patient&#8217;s physician consider it appropriate. Treatment with somatropin should be initiated and managed by a physician with expertise in growth hormone disorders; maintenance treatment can be prescribed in the community under a shared-care protocol.\n\nwww.nice.org.uk/TA64",
                "html": "<p outputclass=\"title\">Somatropin for adults with growth hormone deficiency (August 2003)</p> <p>Somatropin is recommended in adults <b>only</b> if the following 3 criteria are fulfilled:</p> <ul> <li>Severe growth hormone deficiency, established by an appropriate method,</li> <li>Impaired quality of life, measured by means of a specific questionnaire,</li> <li>Already receiving treatment for another pituitary hormone deficiency.</li> </ul> <p>Somatropin treatment should be discontinued if the quality of life has not improved sufficiently by 9 months.</p> <p>Severe growth hormone deficiency developing after linear growth is complete but before the age of 25 years should be treated with growth hormone; treatment should continue until adult peak bone mass has been achieved. Treatment for adult-onset growth hormone deficiency should be stopped only when the patient and the patient&#8217;s physician consider it appropriate.</p> <p>Treatment with somatropin should be initiated and managed by a physician with expertise in growth hormone disorders; maintenance treatment can be prescribed in the community under a shared-care protocol.</p><xref format=\"html\" href=\"http://www.nice.org.uk/TA64\">www.nice.org.uk/TA64</xref>"
            },
            {
                "type": "niceTechnologyAppraisals",
                "references": [
                    {
                        "id": "http://www.nice.org.uk/TA188",
                        "label": "www.nice.org.uk/TA188"
                    }
                ],
                "fundingIdentifier": "NICE TA188",
                "textContent": "Somatropin for the treatment of growth failure in children (May 2010) Somatropin is recommended for children with growth failure who: have growth-hormone deficiency have Turner syndrome have Prader-Willi syndrome have chronic renal insufficiency are born small for gestational age with subsequent growth failure at 4 years of age or later have short stature homeobox-containing gene (SHOX) deficiency. Treatment should be discontinued if growth velocity increases by less than 50% from baseline in the first year of treatment.\n\nwww.nice.org.uk/TA188",
                "html": "<p outputclass=\"title\">Somatropin for the treatment of growth failure in children (May 2010) </p> <p>Somatropin is recommended for children with growth failure who:</p> <ul> <li>have growth-hormone deficiency</li> <li>have Turner syndrome</li> <li>have Prader-Willi syndrome</li> <li>have chronic renal insufficiency</li> <li>are born small for gestational age with subsequent growth failure at 4 years of age or later</li> <li>have short stature homeobox-containing gene (SHOX) deficiency.</li> </ul> <p>Treatment should be discontinued if growth velocity increases by less than 50% from baseline in the first year of treatment.</p><xref format=\"html\" href=\"http://www.nice.org.uk/TA188\">www.nice.org.uk/TA188</xref>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP75165",
                "label": "Solution for injection",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75158",
                "label": "Powder and solvent for solution for injection",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP97239",
                "label": "Controlled drugs and drug dependence",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78434",
                "label": "Hypothalamic and anterior pituitary hormones",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_848",
                "label": "Somatropin",
                "type": "interaction"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP75165",
                "label": "Solution for injection",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75158",
                "label": "Powder and solvent for solution for injection",
                "type": "medicinalForm"
            }
        ]
    }
}